[go: up one dir, main page]

UY26861A1 - Composición de eletriptan en forma de partículas - Google Patents

Composición de eletriptan en forma de partículas

Info

Publication number
UY26861A1
UY26861A1 UY26861A UY26861A UY26861A1 UY 26861 A1 UY26861 A1 UY 26861A1 UY 26861 A UY26861 A UY 26861A UY 26861 A UY26861 A UY 26861A UY 26861 A1 UY26861 A1 UY 26861A1
Authority
UY
Uruguay
Prior art keywords
composition
eletriptan
pharmaceutical composition
core
particles
Prior art date
Application number
UY26861A
Other languages
English (en)
Inventor
Manaud Pierre De Raspide
Ross James Macrae
Mathias Walther
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of UY26861A1 publication Critical patent/UY26861A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Electroluminescent Light Sources (AREA)
  • Luminescent Compositions (AREA)

Abstract

Esta invención proporciona una composición farmacéutica en forma de partículas, adecuada para la administración por vía oral, que incluye un núcleo que contiene eletriptan o una sal farmacéuticamente aceptable del mismo, estando revestido el núcleo con un revestimiento insoluble en agua, y permeable, que incluyen uno o más copolímeros acrílicos que contienen grupos de metacrilato de trimetilamonioetilo, y siendo dicha composición capaz de conseguir un curso sigmoideo de liberación controlada del fármaco. Esta composición farmacéutica es particularmente útil en la prevención de la recurrencia de la migrana.
UY26861A 2000-08-02 2001-07-30 Composición de eletriptan en forma de partículas UY26861A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0018968.8A GB0018968D0 (en) 2000-08-02 2000-08-02 Particulate composition

Publications (1)

Publication Number Publication Date
UY26861A1 true UY26861A1 (es) 2002-02-28

Family

ID=9896843

Family Applications (1)

Application Number Title Priority Date Filing Date
UY26861A UY26861A1 (es) 2000-08-02 2001-07-30 Composición de eletriptan en forma de partículas

Country Status (38)

Country Link
US (1) US20020034545A1 (es)
EP (1) EP1365748B1 (es)
JP (1) JP2004505034A (es)
KR (1) KR20030024820A (es)
CN (1) CN1630511A (es)
AP (1) AP2001002233A0 (es)
AR (1) AR030099A1 (es)
AT (1) ATE308978T1 (es)
AU (1) AU2001270932A1 (es)
BG (1) BG107361A (es)
BR (1) BR0112839A (es)
CA (1) CA2417887C (es)
CZ (1) CZ2003241A3 (es)
DE (1) DE60114887T2 (es)
EA (1) EA200300110A1 (es)
EC (1) ECSP034451A (es)
EE (1) EE200300051A (es)
ES (1) ES2250429T3 (es)
GB (1) GB0018968D0 (es)
GT (1) GT200100149A (es)
HR (1) HRP20030036A2 (es)
HU (1) HUP0301453A2 (es)
IL (1) IL153494A0 (es)
IS (1) IS6649A (es)
MA (1) MA26934A1 (es)
MX (1) MXPA03000999A (es)
NO (1) NO20030498L (es)
NZ (1) NZ522976A (es)
OA (1) OA12348A (es)
PA (1) PA8523101A1 (es)
PE (1) PE20020385A1 (es)
PL (1) PL359847A1 (es)
SK (1) SK1082003A3 (es)
SV (1) SV2002000574A (es)
TN (1) TNSN01115A1 (es)
UY (1) UY26861A1 (es)
WO (1) WO2002009675A1 (es)
ZA (1) ZA200300868B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040022853A1 (en) * 2001-04-26 2004-02-05 Control Delivery Systems, Inc. Polymer-based, sustained release drug delivery system
EP1572107A1 (en) * 2002-12-16 2005-09-14 CHX Technologies Inc. Temporary, pharmacologically-inactive dental coating for the "in situ" protection of dental therapeutic agents from saliva and abrasion from chewing
BRPI0409127A (pt) * 2003-04-11 2006-03-28 Pfizer combinação farmacêutica compreendendo eletriptano e bicarbonato de sódio
GB2407498B (en) * 2003-10-30 2008-06-11 Cipla Ltd Oral formulations for 5-HT receptor agonists with reduced degradation of active ingredient
WO2005120456A2 (en) * 2004-06-09 2005-12-22 Pfizer Limited Formulation of eletriptan
WO2006013431A1 (en) * 2004-07-29 2006-02-09 Pfizer Limited Stable controlled-release pharmaceutical formulation of eletriptan
EP1847268A1 (en) * 2005-01-31 2007-10-24 Kyorin Pharmaceutical Co., Ltd. Multiple unit oral sustained release preparation and process for production of the same
WO2007016948A1 (de) 2005-08-10 2007-02-15 Add Advanced Drug Delivery Technologies Ltd. Orales präparat mit kontrollierter freisetzung
US20070134322A1 (en) * 2005-12-14 2007-06-14 Forest Laboratories, Inc. Modified and pulsatile release pharmaceutical formulations of escitalopram
ATE496623T1 (de) 2006-04-26 2011-02-15 Supernus Pharmaceuticals Inc Oxcarbazepin-zubereitungen für kontrollierte freisetzung mit sigmoidalem freisetzungsprofil
WO2008115797A1 (en) * 2007-03-16 2008-09-25 Pavo, Inc. Therapeutic compositions and methods
CN101820887A (zh) 2007-07-25 2010-09-01 拜奥雷克斯治疗公司 干扰素控释药品以及使用相同药品治疗hcv感染
BR112012011554A2 (pt) * 2009-11-16 2016-06-28 Evonik Roehm Gmbh processo para converter um copolímero de (met) acrilato sólido em uma forma dispersa por meio de um agente de dispersão
GB2535257A (en) * 2014-09-09 2016-08-17 Charleston Laboratories Inc Pharmaceutical compositions
GB201716716D0 (en) * 2017-10-12 2017-11-29 Univ Of Hertfordshire Higher Education Corporation Method for coating particles

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2624732B1 (fr) * 1987-12-21 1991-02-15 Synthelabo Formulation pharmaceutique a liberation prolongee
US5411745A (en) * 1994-05-25 1995-05-02 Euro-Celtique, S.A. Powder-layered morphine sulfate formulations
GB9417310D0 (en) * 1994-08-27 1994-10-19 Pfizer Ltd Therapeutic agents
GB9825988D0 (en) * 1998-11-27 1999-01-20 Pfizer Ltd Indole derivatives
GB9922963D0 (en) * 1999-09-28 1999-12-01 Pfizer Ltd Polymorphic salt
FR2795962B1 (fr) * 1999-07-08 2003-05-09 Prographarm Laboratoires Procede de fabrication de granules enrobes a gout masque et liberation immediate du principe actif
US20020044962A1 (en) * 2000-06-06 2002-04-18 Cherukuri S. Rao Encapsulation products for controlled or extended release

Also Published As

Publication number Publication date
IL153494A0 (en) 2003-07-06
OA12348A (en) 2004-03-19
CN1630511A (zh) 2005-06-22
AP2001002233A0 (en) 2001-09-30
DE60114887T2 (de) 2006-07-20
MA26934A1 (fr) 2004-12-20
ATE308978T1 (de) 2005-11-15
SV2002000574A (es) 2002-12-02
CZ2003241A3 (cs) 2004-02-18
HRP20030036A2 (en) 2003-04-30
ZA200300868B (en) 2004-04-16
WO2002009675A1 (en) 2002-02-07
IS6649A (is) 2002-12-05
EA200300110A1 (ru) 2003-06-26
US20020034545A1 (en) 2002-03-21
EP1365748B1 (en) 2005-11-09
AR030099A1 (es) 2003-08-13
GT200100149A (es) 2002-06-25
EE200300051A (et) 2004-10-15
NO20030498D0 (no) 2003-01-31
TNSN01115A1 (fr) 2005-11-10
SK1082003A3 (en) 2004-09-08
PL359847A1 (pl) 2004-09-06
NZ522976A (en) 2004-11-26
MXPA03000999A (es) 2003-06-09
HUP0301453A2 (hu) 2003-08-28
NO20030498L (no) 2003-01-31
DE60114887D1 (de) 2005-12-15
BG107361A (bg) 2003-06-30
BR0112839A (pt) 2003-06-24
PE20020385A1 (es) 2002-05-11
ECSP034451A (es) 2003-03-10
CA2417887C (en) 2006-11-14
WO2002009675A9 (en) 2003-09-18
JP2004505034A (ja) 2004-02-19
GB0018968D0 (en) 2000-09-20
ES2250429T3 (es) 2006-04-16
CA2417887A1 (en) 2002-02-07
PA8523101A1 (es) 2002-08-26
AU2001270932A1 (en) 2002-02-13
EP1365748A2 (en) 2003-12-03
KR20030024820A (ko) 2003-03-26

Similar Documents

Publication Publication Date Title
UY26861A1 (es) Composición de eletriptan en forma de partículas
CY1106072T1 (el) Φαρμακευτικη μορφη δοσης παρατεταμενης αποδεσμευσης απο του στοματος
ATE391496T1 (de) Geschmacksmaskierte pharmazeutische formulierungen
DE60237372D1 (de) Magenretentionssystem mit kontrollierter arzneimittelfreisetzung
ES2524556T3 (es) Composiciones farmacéuticas
DOP2001000229A (es) Forma de dosificación de fármaco activada por hidrogel
IL173078A0 (en) Multiparticle pharmaceutical dosage form containing a mucoadhesively formulated peptide or protein active substances method for producing said pharmaceutical dosage form
CO5261492A1 (es) Formas de dosificacion de liberacion controlada que comprenden zolpidem o sales del mismo
ATE266390T1 (de) Stossweise freisetzende arzneiabgabesysteme
CY1112517T1 (el) Φαρμακοτεχνικες μορφες τροποποιημενης αποδεσμευσης μιας τουλαχιστον μορφης τραμαδολης
ES2531215T3 (es) Sistemas de administración de fármacos que comprenden un agente de bloqueo selectivo de la serotonina 5-HT3 débilmente básico y ácidos orgánicos
ATE482694T1 (de) Zusammensetzung zur kontrollierten wirkstoffabgabe
EE200200343A (et) Asaindooli sisaldav farmatseutiline kompositsioonraviotstarbeliseks kasutamiseks, asaindoolid ningnende kasutamine ravimite valmistamiseks, mis on ette nähtud proteiinikinaasi katalüütilise toime pärssimiseks
DE60310039D1 (de) Pharmazeutische tablette
ES2091970T3 (es) Formulaciones farmaceuticas gastrorresistentes de liberacion controlada para administracion oral que contienen acidos biliares y sus sales.
DK1345595T3 (da) Ionstyrke-uafhængig farmaceutisk formulering med depotfrigivelse
KR950031052A (ko) 알푸조신 히드로클로라이드의 서방성 투약형태
BR0013719A (pt) Dosagem oral de liberaçâo controlada, apropriada para administração oral
ATE367153T1 (de) Multipartikuläre arzneizusammensetzungen mit gesteuerter wirkstoffabgabe enthaltend selektive inhibitoren der serotoninwiederaufnahme
WO2004062552A3 (en) Pharmaceutical composition containing a nsaid and a benzimidazole derivative
AR011437A1 (es) Composicion farmaceutica para el tratamiento de la migrana y el uso de la misma en la preparacion de un medicamento.
BR0215366A (pt) Formulações transdérmicas adesivas de diclofenac sódico
ECSP066318A (es) Composición para la liberación de una base debil por un periodo extendido de tiempo
ES2182524T3 (es) Composiciones de hidroxiomeprazol y sus utilizaciones.
AR040461A1 (es) Microcapsulas para la liberacion retardada y controlada de perindopril

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20140625